Celgene

Associate Director, Pricing- Cardiovascular & Established Brands

Posted on: 6 Dec 2021

Princeton, NJ

Job Description

Job Description

At Bristol Myers Squibb, we are inspired by a single vision – transforming patients’ lives through science. In oncology, hematology, immunology and cardiovascular disease – and one of the most diverse and promising pipelines in the industry – each of our passionate colleagues contribute to innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. Join us and make a difference.

Associate Director of Pricing- Cardiovascular & Established Brands

Overview:

The Associate Director Role on The Cardiovascular (CV) Pricing team evaluates the strategic implications of channel dynamics and ecosystem changes, and uses these insights to identify value-creating opportunities, and develop innovative pricing strategies for CV brands over their entire product life cycle.  This role works closely with the CV access team to ensure implementation of value-creating pricing strategies and activities. The AD utilizes a deep understanding of BMS' CV portfolio, profitability objectives, health economics outcomes research, customer profiles, and the business environment to analyze pricing scenarios and formulate innovative pricing models. This position supports the integrated customer team and brings a strong analytical mindset and skills to aid in account and channel-specific access strategy development.  The AD is responsible for identifying and evaluating creative and innovative pricing approaches in consideration of the evolving access landscape.

Detailed Description:

Develops and maintains a comprehensive, value-creating pricing strategy for CV and Established  brands, ensuring they maintain strategic prominence with the customer in line with overall brand strategy

Responsible for tracking and communicating competitive activities, as well as changes in the marketplace and the regulatory environment that impact pricing strategies

Partners with the HEOR to ensure pricing strategies leverage and consider real world evidence

Identifies future supporting evidence needs in partnership with CV brands

Utilizes sophisticated analytics and strong financial acumen to evaluate impact of pricing scenarios on volume/revenue

Works with CV brand access team for developing a comprehensive Gross to Net (GTN) strategy over the life cycle of the molecule, including the launch price, list price, discounts, etc.

Initiates market research activities in support of CV pricing strategy and develops standardized methodologies and approaches for analyzing tiered pricing models, conducting pricing sensitivity analysis, and segmenting payers

Links brand value proposition with GTN strategy, and develops of innovative programs like value-based contracting

Assists the brand in evaluating the potential impact of value-creating programs, such as co-pay assistance, and the influence these programs have on various contracting options

Works successfully across the matrix to balance the needs of and input from multiple stakeholders (e.g., the brand, Finance, Federal and Policy teams, HEOR, payer marketing , etc.) who may influence the ultimate pricing/contracting decision

Maintains close partnership and coordination with the RAE/NAE account leads and Contract Operations in support of contract implementation with the customer

Maintains close partnerships with others in VAP in exchanging insights and best practices, as well as leveraging skills to optimize pricing and contracting strategies across the portfolio

Ensure close coordination with peers and key matrix partners, such as Finance, on budgeting and projections

Candidate Specifications:

Candidate must have a BA/BS degree or equivalent

A minimum of 5 years’ experience in the pharmaceutical/healthcare industry is strongly advised

Understands unique challenges and business drivers across multiple channels, (e.g., payers, IDNs, GPOs, pathway organization), and how these influence the customers’ receptivity to various pricing schemes and contracting models

Strong analytical skills and an ability to evaluate the impact of various pricing approaches which could be employed in a complex ecosystem/marketplace

Solid business acumen including an understanding of the ways various customer types make money and create value

Solid communication skills, the ability to work across boundaries in an internal matrix organization, and the capability to form strong, productive partnerships

Experience in negotiating, executing, and implementing contracts

Strong aptitude for learning quickly and an ability to communicate technical concepts to a wide range of stakeholders

Demonstrated ability to drive execution of key initiatives and meet all deadlines

Ability to prioritize and work effectively in a fast-paced, dynamic environment

Track record of highly ethical and compliant behavior

Preferred Qualifications:

Advanced degree in Finance, Economics, Health Economics or a similar discipline is a plus

 

Celgene

Summit, NJ

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of cancer and inflammatory diseases worldwide. It offers REVLIMID, an oral immunomodulatory drug for multiple myeloma (MM), myelodysplastic syndromes (MDS), and mantle cell lymphoma; POMALYST/IMNOVID to treat multiple myeloma; OTEZLA, a small-molecule inhibitor of phosphodiesterase 4 for psoriatic arthritis and psoriasis; and ABRAXANE to treat breast, non-small cell lung, pancreatic, and gastric cancers.

The company’s products also include IDHIFA for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (rrAML) with an isocitrate dehydrogenase-2 mutation; VIDAZA, a pyrimidine nucleoside analog for intermediate-2 and high-risk MDS, chronic myelomonocytic leukemia, and AML; THALOMID to treat patients with MM; and ISTODAX, an epigenetic modifier. Its preclinical and clinical-stage product candidates include small molecules, biologics, and cell therapies for immune-inflammatory diseases, myeloid diseases, epigenetics, protein homeostasis, and immuno-oncology.

The company has agreements with BeiGene, Ltd; Acceleron Pharma, Inc.; Agios Pharmaceuticals, Inc.; bluebird bio, Inc.; Lycera Corp.; Juno Therapeutics, Inc.; EXSCIENTIA LTD.; and IMIDomics SL, as well as immuno-oncology collaboration with Sutro Biopharma. Celgene Corporation was founded in 1980 and is headquartered in Summit, New Jersey.

Similar Jobs